In laboratory dish experiments conducted with biologists at Winship Cancer Institute of Emory University, the researchers showed the compound's efficacy against HER2-positive breast cancer cells ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA. The first patient with metastatic ...

is proud to announce the publication of a groundbreaking study demonstrating the clinical impact of HER2DX ®, its genomic diagnostic test designed for early-stage HER2-positive (HER2+) breast cancer.